Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Lyell Immunopharma Current Ratio 2020-2024 | LYEL

Lyell Immunopharma current ratio from 2020 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Lyell Immunopharma Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-09-30 $0.45B $0.03B 13.43
2024-06-30 $0.50B $0.03B 16.19
2024-03-31 $0.53B $0.03B 16.51
2023-12-31 $0.56B $0.04B 16.07
2023-09-30 $0.59B $0.04B 16.74
2023-06-30 $0.61B $0.03B 17.63
2023-03-31 $0.62B $0.03B 20.28
2022-12-31 $0.65B $0.04B 17.59
2022-09-30 $0.66B $0.05B 12.88
2022-06-30 $0.67B $0.05B 13.26
2022-03-31 $0.63B $0.04B 15.24
2021-12-31 $0.63B $0.05B 13.40
2021-09-30 $0.63B $0.06B 10.65
2021-06-30 $0.84B $0.06B 13.11
2021-03-31 $0.00B 0.00
2020-12-31 $0.00B 0.00
2020-09-30 $0.00B 0.00
2020-06-30 $0.00B 0.00
2019-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.179B $0.000B
Lyell Immunopharma Inc. is a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors. Lyell Immunopharma Inc. is based in SOUTH SAN FRANCISCO, Calif.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $74.307B 28.59
Chugai Pharmaceutical (CHGCY) Japan $72.436B 28.22
Takeda Pharmaceutical (TAK) Japan $41.905B 8.72
Merck (MKKGY) Germany $18.621B 16.67
Sandoz Group AG (SDZNY) Switzerland $18.176B 0.00
Astellas Pharma (ALPMY) Japan $17.463B 16.08
United Therapeutics (UTHR) United States $16.111B 15.85
Summit Therapeutics (SMMT) United States $14.012B 0.00
Neurocrine Biosciences (NBIX) United States $13.823B 36.60
Shionogi (SGIOY) Japan $11.910B 11.93
Madrigal Pharmaceuticals (MDGL) United States $6.805B 0.00
Orion OYJ (ORINY) Finland $6.196B 17.42
Ionis Pharmaceuticals (IONS) United States $5.768B 0.00
Corcept Therapeutics (CORT) United States $5.466B 41.40
Crinetics Pharmaceuticals (CRNX) United States $5.002B 0.00
PTC Therapeutics (PTCT) United States $3.498B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.579B 11.69
Dyne Therapeutics (DYN) United States $2.439B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.432B 14.54
NewAmsterdam Pharma (NAMS) Netherlands $2.397B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.225B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.075B 0.00
Soleno Therapeutics (SLNO) United States $1.930B 0.00
Evotec AG (EVO) Germany $1.772B 0.00
Xencor (XNCR) United States $1.700B 0.00
Indivior (INDV) United States $1.653B 6.74
BioCryst Pharmaceuticals (BCRX) United States $1.589B 0.00
Guardian Pharmacy Services (GRDN) United States $1.401B 0.00
Ocular Therapeutix (OCUL) United States $1.310B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.286B 0.00
Harrow (HROW) United States $1.205B 0.00
Enliven Therapeutics (ELVN) United States $1.131B 0.00
ARS Pharmaceuticals (SPRY) United States $1.109B 0.00
Ardelyx (ARDX) United States $1.099B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.986B 0.00
Collegium Pharmaceutical (COLL) United States $0.937B 5.12
Bioventus (BVS) United States $0.867B 27.39
Cronos Group (CRON) Canada $0.765B 0.00
Oruka Therapeutics (ORKA) United States $0.740B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.738B 0.00
Relay Therapeutics (RLAY) United States $0.708B 0.00
USANA Health Sciences (USNA) United States $0.699B 12.95
Elite Pharmaceuticals (ELTP) United States $0.572B 0.00
Savara (SVRA) United States $0.549B 0.00
Tourmaline Bio (TRML) United States $0.549B 0.00
Altimmune (ALT) United States $0.537B 0.00
ProKidney (PROK) United States $0.519B 0.00
Xeris Biopharma Holdings (XERS) United States $0.517B 0.00
OmniAb (OABI) United States $0.498B 0.00
Verve Therapeutics (VERV) United States $0.489B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.484B 0.00
Zevra Therapeutics (ZVRA) United States $0.459B 0.00
Esperion Therapeutics (ESPR) United States $0.453B 0.00
KalVista Pharmaceuticals (KALV) United States $0.433B 0.00
Siga Technologies (SIGA) United States $0.428B 5.00
Akebia Therapeutics (AKBA) United States $0.406B 0.00
Korro Bio (KRRO) United States $0.406B 0.00
Organogenesis (ORGO) United States $0.400B 0.00
Jupiter Neurosciences (JUNS) United States $0.375B 0.00
Avita Medical (RCEL) United States $0.338B 0.00
Aquestive Therapeutics (AQST) United States $0.321B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.290B 117.43
Aldeyra Therapeutics (ALDX) United States $0.283B 0.00
Nature's Sunshine Products (NATR) United States $0.279B 16.57
Amylyx Pharmaceuticals (AMLX) United States $0.274B 0.00
4D Molecular Therapeutics (FDMT) United States $0.269B 0.00
Larimar Therapeutics (LRMR) United States $0.241B 0.00
Heron Therapeutics (HRTX) United States $0.240B 0.00
Innate Pharma SA (IPHYF) France $0.233B 0.00
Lexeo Therapeutics (LXEO) United States $0.210B 0.00
Profound Medical (PROF) Canada $0.210B 0.00
Silence Therapeutics (SLN) United Kingdom $0.210B 0.00
Aclaris Therapeutics (ACRS) United States $0.207B 0.00
Inhibikase Therapeutics (IKT) United States $0.199B 0.00
Acrivon Therapeutics (ACRV) United States $0.194B 0.00
MediWound (MDWD) Israel $0.193B 0.00
Nektar Therapeutics (NKTR) United States $0.167B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.160B 0.00
Telomir Pharmaceuticals (TELO) United States $0.147B 0.00
Metagenomi (MGX) United States $0.141B 0.00
CytoDyn (CYDY) United States $0.140B 0.00
Nanobiotix S.A (NBTX) France $0.139B 0.00
VAXART, INC (VXRT) United States $0.138B 0.00
Achieve Life Sciences (ACHV) Canada $0.130B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.129B 0.00
Inotiv (NOTV) United States $0.118B 0.00
Cassava Sciences (SAVA) United States $0.113B 0.00
Champions Oncology (CSBR) United States $0.109B 0.00
Protara Therapeutics (TARA) United States $0.107B 0.00
ElectroCore (ECOR) United States $0.107B 0.00
Cardiol Therapeutics (CRDL) Canada $0.103B 0.00
Regulus Therapeutics (RGLS) United States $0.101B 0.00
Pyxis Oncology (PYXS) United States $0.095B 0.00
Journey Medical (DERM) United States $0.094B 0.00
Fractyl Health (GUTS) United States $0.092B 0.00
Avalo Therapeutics (AVTX) United States $0.092B 0.00
Century Therapeutics (IPSC) United States $0.087B 0.00
Context Therapeutics (CNTX) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
Assertio Holdings (ASRT) United States $0.084B 21.90
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Karyopharm Therapeutics (KPTI) United States $0.075B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.072B 0.00
ESSA Pharma (EPIX) Canada $0.071B 0.00
Unicycive Therapeutics (UNCY) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Prelude Therapeutics (PRLD) United States $0.065B 0.00
Scienture Holdings (SCNX) United States $0.064B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.060B 0.00
OptiNose (OPTN) United States $0.057B 0.00
Mural Oncology (MURA) Ireland $0.055B 0.00
AlloVir (ALVR) United States $0.055B 0.00
Galectin Therapeutics (GALT) United States $0.053B 0.00
FibroGen (FGEN) United States $0.050B 0.00
Swiftmerge Acquisition (ANNA) United States $0.048B 0.00
Iterum Therapeutics (ITRM) Ireland $0.048B 0.00
Rafael Holdings (RFL) United States $0.044B 0.00
VYNE Therapeutics (VYNE) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.044B 0.00
Nutriband (NTRB) United States $0.043B 0.00
Gain Therapeutics (GANX) United States $0.042B 0.00
Surrozen (SRZN) United States $0.040B 0.00
BioVie (BIVI) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Tempest Therapeutics (TPST) United States $0.037B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.035B 0.00
Traws Pharma (TRAW) United States $0.035B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.031B 0.00
Incannex Healthcare (IXHL) Australia $0.031B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.030B 0.00
DURECT (DRRX) United States $0.030B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Mannatech (MTEX) United States $0.021B 0.00
NRx Pharmaceuticals (NRXP) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
MEI Pharma (MEIP) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.014B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Viracta Therapeutics (VIRX) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Dominari Holdings (DOMH) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Conduit Pharmaceuticals (CDT) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.09
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
Phio Pharmaceuticals (PHIO) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
Molecular Templates (MTEM) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.77
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 41.18